v3.22.2.2

STOCK WARRANTS, STOCK OPTIONS AND RESTRICTED STOCK UNITS (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2022 | Dec. 31, 2021
STOCK WARRANTS, STOCK OPTIONS AND RESTRICTED STOCK UNITS (Tables) |  |
Schedule Of Fair Value Of Non-employee Stock/warrants |  |
|  | December 31, 2021 |  |  | December 31, 2020 |
Exercise Price |  | $ | 9.00-$6.00 |  |  | $ | 1.50-$6.00 |
Dividend Yield |  |  | 0 | % |  |  | 0 | %
Volatility |  |  | 120%-158 | % |  |  | 153% - 154 | %
Risk-free Interest Rate |  |  | 0.14%- 0.98 | % |  |  | 0.19% – 0.29 | %
Life of Warrants |  |  | 2-5 Years |  |  |  | 5 Years |
|  | Warrants Outstanding Number of Shares |  |  | Exercise Price Per Share |  | Weighted Average Remaining Contractual Life |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2019 |  |  | 199,471 |  |  | $ | 0.39912 -3.118125 |  |  | 3.97 Years |  |  | $ | 1.0776 |  |  | $ | 1,276,870 |
Warrants Granted |  |  | 146,667 |  |  | $ | 1.50 - 6.00 |  |  | 4.41 Years |  |  | $ | 2.7273 |  |  | $ | 898,000 |
Warrants Exercised |  |  | (151,366 | ) |  | $ | 0.39912 - 0.45897 |  |  |  |  |  | $ | 0.4353 |  |  |  |  |
Warrants Expired |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2020 |  |  | 194,772 |  |  | $ | 1.50 – 6.00 |  |  | 3.80 Years |  |  | $ | 2.8239 |  |  | $ | 1,173,737 |
|  | Warrants Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2020 |  |  | 194,772 |  |  | $ | 1.50 – 6.00 |  |  | 3.80 Years |  | $ | 2.8239 |  |  | $ | 1,173,737 |
Warrants Granted |  |  | 740,671 |  |  | $ | 9.00-6.00 |  |  | 3.15 Years |  | $ | 7.3500 |  |  | $ | 1,152,852 |
Warrants Exercised |  |  | (58,979 | ) |  | $ | 1.50 |  |  |  |  | $ | 1.5000 |  |  |  |  |
Warrants Expired/Forfeited |  |  | (40,000 | ) |  | $ | 6.00 |  |  |  |  | $ | 6.0000 |  |  |  |  |
Balance at December 31, 2021 |  |  | 836,464 |  |  | $ | 1.50 – 9.00 |  |  | 3.04 Years |  | $ | 6.7800 |  |  | $ | 1,784,838 |
Schedule of fair value of warrant and stock options granted |
|  | June 30, 2022 |  |  | June 30, 2021 |
Exercise Price |  | $ | 4.25-6.00 |  |  | $ | 9.00 |
Dividend Yield |  |  | 0 | % |  |  | 0 | %
Volatility |  | 110–160 | % |  |  | 158 | %
Risk-free Interest Rate |  |  | 2.45-2.89 | % |  |  | 0.14 | %
Life of Warrants |  | 5 – 7 Years |  |  | 2 Years |
|  | June 30, 2022 |  |  | June 30, 2021 |
Exercise Price |  | $ | 8.2500 – 9.0750 |  |  | $ | 8.3100 |
Dividend Yield |  |  | 0 | % |  |  | 0 | %
Volatility |  |  | 191% - 192% | % |  |  | 152%-158 | %
Risk-free Interest Rate |  |  | 0.78% - 1.52 | % |  |  | 0.27%-0.34 | %
Life of Options |  | 2 – 3 Years |  |  | 2 – 5 Years |
|  | December 31, 2021 |  |  | December 31, 2020 |
Exercise Price |  | $ | 8.31-10.74 |  |  | $ | 4.9350-9.90 |
Dividend Yield |  |  | 0 | % |  |  | 0 | %
Expected Volatility |  | 138%-198 | % |  | 162%-181 | %
Risk-free Interest Rate |  | 0.10%-0.79 | % |  | 0.19%-0.43 | %
Expected Life |  | 2.7- 6.2 years |  |  | 1-2.7 years |
Schedule of warrant And Option outstanding Stock |
|  | Warrants Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2020 |  |  | 194,772 |  |  | $ | 1.50– 6.00 |  |  | 3.80 Years |  | $ | 2.82 |  |  | $ | 1,173,737 |
Warrants Granted |  |  | 334,167 |  |  | $ | 9.00 |  |  | 1.79 Years |  | $ | 9.00 |  |  | $ | 952,375 |
Warrants Exercised |  |  | (58,979 | ) |  | $ | 1.50 |  |  |  |  | $ | 1.50 |  |  |  |  |
Warrants Expired |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at June 30, 2021 |  |  | 469,960 |  |  | $ | 1.50– 9.00 |  |  | 2.52 Years |  | $ | 7.38 |  |  | $ | 2,099,093 |
|  | Warrants Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2021 |  |  | 836,464 |  |  | $ | 1.50– 9.00 |  |  | 3.04 Years |  | $ | 6.78 |  |  | $ | 1,784,838 |
Warrants Granted |  |  | 5,372,803 |  |  | $ | 4.25– 6.00 |  |  | 4.92 Years |  | $ | 4.31 |  |  | $ | - |
Warrants Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants Expired/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at June 30, 2022 |  |  | 6,209,267 |  |  | $ | 1.50– 9.00 |  |  | 4.74 Years |  | $ | 4.64 |  |  | $ | - |
|  | Options Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2020 |  |  | 857,409 |  |  | $ | 0.7902 – 9.9000 |  |  | 7.45 Years |  | $ | 1.4997 |  |  | $ | 6,302,277 |
Options Granted |  |  | 129,167 |  |  |  | 8.3160 – 10.1310 |  |  | 2.94 Years |  |  | 9.8562 |  |  |  | 257,540 |
Options Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options Cancelled |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options Expired/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at June 30, 2021 |  |  | 986,576 |  |  | $ | 0.7902 – 10.1310 |  |  | 7.21 Years |  | $ | 2.5938 |  |  | $ | 9,132,060 |
|  | Options Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2021 |  |  | 1,053,356 |  |  | $ | 0.7903 – 10.74 |  |  | 6.21 Years |  | $ | 3.3900 |  |  | $ | 5,804,517 |
Options Granted |  |  | 70,000 |  |  | $ | 8.25 – 9.0750 |  |  | 1.58 Years |  | $ | 8.2893 |  |  | $ | - |
Options Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options Cancelled |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options Expired/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at June 30, 2022 |  |  | 1,123,356 |  |  | $ | 0.7903 – 10.7250 |  |  | 5.46 Years |  | $ | 3.7042 |  |  | $ | - |
|  | Options Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Exercisable at December 31, 2021 |  |  | 635,609 |  |  | $ | 0.7903 - 10.7400 |  |  | 6.70 Years |  | $ | 1.5861 |  |  | $ | 4,655,089 |
Exercisable at June 30, 2022 |  |  | 846,269 |  |  | $ | 0.7903 – 10.7250 |  |  | 6.45 Years |  | $ | 2.5032 |  |  | $ | - |
|  | Options Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2019 |  |  | 793,747 |  |  | $ | 0.7902 – 3.1170 |  |  | 9.00 Years |  | $ | 0.8283 |  |  | $ | 5,238,080 |
Granted |  |  | 23,965 |  |  | $ | 4.95-9.90 |  |  | 2.39 Years |  | $ | 6.4500 |  |  | $ | 57,815 |
Exercised |  |  | (15,302 | ) |  | $ | 3.117 |  |  |  |  |  |  |  |  |  |  |
Cancelled/Expired/Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2020 |  |  | 802,409 |  |  | $ | 0.792 – 9.90 |  |  | 7.86 Years |  | $ | 1.0077 |  |  | $ | 6,292,844 |
|  | Options Outstanding Number of Shares |  |  | Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value |
Balance at December 31, 2020 |  |  | 802,409 |  |  | $ | 0.792 – 9.90 |  |  | 7.86 Years |  | $ | 1.0077 |  |  | $ | 6,292,844 |
Granted |  |  | 386,667 |  |  | $ | 8.31 – 10.74 |  |  | 3.87 Years |  | $ | 9.6900 |  |  | $ | (301,815 | )
Exercised |  |  | (24,369 | ) |  | $ | 0.79 |  |  |  |  | $ | 0.7902 |  |  |  |  |
Cancelled/Expired/Forfeited |  |  | (111,351 | ) |  | $ | 0.7902-9.87 |  |  |  |  | $ | 8.5800 |  |  |  |  |
Balance at December 31, 2021 |  |  | 1,053,356 |  |  | $ | 0.7903 – 10.74 |  |  | 6.21 Years |  | $ | 3.3900 |  |  | $ | 5,804,517 |
Exercisable at December 31, 2020 |  |  | 417,491 |  |  | $ | 0.7902 – 9.90 |  |  | 7.4 Years |  | $ | 0.9495 |  |  | $ | 3,299,006 |
Exercisable at December 31, 2021 |  |  | 635,609 |  |  | $ | 0.7903 – 10.74 |  |  | 6.7 Years |  | $ | 1.5861 |  |  | $ | 4,655,089 |
Restricted Stock Units |
|  | RSUs |  |  | Weighted Average Grant Date Fair Value Per Share |  |  | Weighted Average Vesting Period |
Unvested at December 31, 2020 |  |  | 71,667 |  |  | $ | 8.7460 |  |  | 1.70 Years |
Granted |  |  | 3,333 |  |  |  | 9.2100 |  |  | 1.50 Years |
Vested |  |  | - |  |  |  |  |  |  |  |
Unvested at June 30, 2021 |  |  | 75,000 |  |  | $ | 8.7667 |  |  | 1.21 Years |
|  | RSUs |  |  | Weighted Average Grant Date Fair Value Per Share |  |  | Weighted Average Vesting Period |
Unvested at December 31, 2021 |  |  | 133,585 |  |  | $ | 8.56 |  |  | 0.97 Years |
Granted |  |  | 41,667 |  |  |  | 6.92 |  |  | 0.52 Years |
Vested |  |  | (16,667 | ) |  |  | 7.50 |  |  |  |
Unvested at June 30, 2022 |  |  | 158,585 |  |  | $ | 8.17 |  |  | 0.49 Years |
|  | RSUs |  |  | Weighted Average Grant Date Fair Value Per Share |  |  | Weighted Average Vesting Period |
Unvested at December 31, 2019 |  |  | - |  |  | $ | - |  |  |  | - |
Granted |  |  | 71,667 |  |  | $ | 8.76 |  |  | 1.69 Years |
Unvested at December 31, 2020 |  |  | 71,667 |  |  | $ | 8.76 |  |  | 1.54 Years |
Granted |  |  | 78,585 |  |  | $ | 8.52 |  |  | 1.35 Years |
Vested |  |  | (16,667 | ) |  | $ | 8.97 |  |  |  |  |
Unvested at December 31, 2021 |  |  | 133,585 |  |  | $ | 8.58 |  |  | 1.00 Years |

X
- References No definition available. + Details
Name: | sobr_RestrictedAssetsDisclosuresTableTextBlock
Namespace Prefix: | sobr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_WarrantsAndRightsNoteDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration